These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6089322)

  • 1. Acute and subacute haemodynamic effects of enalapril. Non-invasive studies of a new converting enzyme inhibitor for antihypertensive treatment.
    Wikstrand J; Herlitz H; Berglund G
    Scand J Urol Nephrol Suppl; 1984; 79():81-5. PubMed ID: 6089322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and Subacute Haemodynamic Effects of Enalapril.
    Wikstrand J; Herlitz H; Berglund G
    Scand J Urol Nephrol; 1984 Jul; 18(sup79):81-85. PubMed ID: 27786010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term haemodynamic effects of enalapril at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    Scand J Urol Nephrol Suppl; 1984; 79():87-91. PubMed ID: 6089323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
    Fouad FM; Tarazi RC; Bravo EL; Textor SC
    Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enalapril and atenolol in primary hypertension--a comparative study of blood pressure lowering and hormonal effects.
    Ohman KP; Karlberg BE
    Scand J Urol Nephrol Suppl; 1984; 79():93-7. PubMed ID: 6089325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
    O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
    J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ACE inhibition on left ventricular dimensions and haemodynamics in systemic hypertension: a radionuclide and echocardiographic study.
    Haznedaroglu IC; Erdem Y; Tokgözoglu L; Caglar M; Kes S; Sayinalp NM; Yörükan S
    Cent Afr J Med; 1995 Apr; 41(4):118-23. PubMed ID: 7788682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH; Myers MG; Joyner CD; Toal CB
    Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and renal effects of enalapril and its effects on cardiac mass.
    Dunn FG; Oigman W; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
    J Hypertens Suppl; 1984 Dec; 2(2):S57-61. PubMed ID: 6100878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
    Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension.
    Fagard R; Lijnen P; Pardaens K; Thijs L; Vinck W
    J Hum Hypertens; 2001 Mar; 15(3):161-7. PubMed ID: 11317199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up.
    Eveson DJ; Robinson TG; Potter JF
    Am J Hypertens; 2007 Mar; 20(3):270-7. PubMed ID: 17324738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac and haemodynamic effects of enalapril.
    Fouad FM; Tarazi RC; Bravo EL
    J Hypertens Suppl; 1983 Oct; 1(1):135-42. PubMed ID: 6100602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of blood pressure control and left ventricular performance with small doses of enalapril.
    González-Juanatey JR; Reino AP; García-Acuña JM; González-Juanatey C; Valdes L; de la Peña MG; Cabezas-Cerrato J
    Am J Cardiol; 1999 Mar; 83(5):719-23. PubMed ID: 10080425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.